The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
SOCIETY: AGA Mechanistic studies in GI diseases, including eosinophilic esophagitis, obesity, inflammatory bowel disease, and intestinal pseudo-obstruction, and therapeutic outcomes such as FMT will be explored.
TREATMENT WITH THE HISTAMINE 1 RECEPTOR ANTAGONIST EBASTINE FOR NON-CONSTIPATED IRRITABLE BOWEL SYNDROME: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL